Institutional
ACT CAPITAL MANAGEMENT, LLC
CIK 0001442273
$127.2M
Reported AUM
56
Positions
Q1 2026
Period
2026-05-08
Filed
The Brief · ACT CAPITAL MANAGEMENT, LLC · Q1 2026
AI · grounded in 13F
ACT CAPITAL MANAGEMENT, LLC closed its position in CELCUITY INC COM MAR 20 26 $50 CALL, reducing its exposure by $3.04M. The fund established new positions in ALMS for $3.84M, FCX for $2.26M, and AAOI for $2.19M. Additionally, the manager exited holdings in GPCR, FIGR, and SPOT.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Ticker | Issuer | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|
| 1 | KRYS | KRYSTAL BIOTECH INC | $15.6M | 12.28% | -23 | -0.0% |
| 2 | CVX | CHEVRON CORP | $15.5M | 12.20% | -3,500 | -4.5% |
| 3 | XOM | EXXON MOBIL CORP | $11.9M | 9.33% | -12,500 | -15.2% |
| 4 | CELC | CELCUITY INC | $10.5M | 8.22% | +28,260 | +44.6% |
| 5 | TGTX | TG THERAPEUTICS INC | $8.3M | 6.50% | -19,850 | -7.4% |
| 6 | ABVX | ABIVAX SA | $7.9M | 6.20% | +7,000 | +11.0% |
| 7 | AMZN | AMAZON.COM INC | $6.9M | 5.40% | +8,400 | +34.1% |
| 8 | VKTX | VIKING THERAPEUTICS INC | $6.8M | 5.35% | +3,200 | +1.6% |
| 9 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $5.2M | 4.07% | +7,500 | +10.0% |
| 10 | NKTR | NEKTAR THERAPEUTICS | $5.1M | 4.01% | +19,700 | +38.5% |
| 11 | CYTK | CYTOKINETICS INC | $4.3M | 3.34% | — | HELD |
| 12 | ALMS | ALUMIS INC | $3.8M | 3.02% | +174,250 | NEW |
| 13 | ET | ENERGY TRANSFER L P | $2.6M | 2.02% | — | HELD |
| 14 | FCX | FREEPORT-MCMORAN INC | $2.3M | 1.78% | +38,500 | NEW |
| 15 | AAOI | APPLIED OPTOELECTRONICS INC | $2.2M | 1.72% | +25,900 | NEW |
| 16 | XENE | XENON PHARMACEUTICALS INC | $1.9M | 1.53% | +33,500 | NEW |
| 17 | NUVB | NUVATION BIO INC | $1.2M | 0.98% | -320,500 | -52.5% |
| 18 | STAA | STAAR SURGICAL CO | $1.0M | 0.82% | — | HELD |
| 19 | PRAX | PRAXIS PRECISION MEDICINES INC | $870K | 0.68% | +2,000 | +285.7% |
| 20 | GBTC | GRAYSCALE BITCOIN TRUST ETF | $813K | 0.64% | -19,000 | -55.2% |
| 21 | S | SENTINELONE INC | $699K | 0.55% | +54,300 | NEW |
| 22 | LITE | LUMENTUM HLDGS INC | $632K | 0.50% | +900 | NEW |
| 23 | BE | BLOOM ENERGY CORP | $610K | 0.48% | -8,500 | -65.4% |
| 24 | CRGY | CRESCENT ENERGY COMPANY | $608K | 0.48% | -16,312 | -26.6% |
| 25 | KURA | KURA ONCOLOGY INC | $601K | 0.47% | — | HELD |
| 26 | VIR | VIR BIOTECHNOLOGY INC | $576K | 0.45% | +64,300 | NEW |
| 27 | CRCL | CIRCLE INTERNET GROUP INC | $572K | 0.45% | +6,000 | NEW |
| 28 | HCC | WARRIOR MET COAL INC | $559K | 0.44% | -6,000 | -50.0% |
| 29 | PATH | UIPATH INC | $555K | 0.44% | +3,000 | +6.4% |
| 30 | SRRK | SCHOLAR ROCK HLDG CORP | $531K | 0.42% | -1,200 | -10.0% |
| 31 | WGS | GENEDX HOLDINGS CORP | $514K | 0.40% | +5,000 | +166.7% |
| 32 | MU | MICRON TECHNOLOGY INC | $507K | 0.40% | +1,500 | NEW |
| 33 | NVDA | NVIDIA CORPORATION | $488K | 0.38% | +2,800 | NEW |
| 34 | REPL | REPLIMUNE GROUP INC | $470K | 0.37% | — | HELD |
| 35 | RGNX | REGENXBIO INC | $469K | 0.37% | -26,500 | -32.1% |
| 36 | PALI | PALISADE BIO INC | $451K | 0.35% | +107,500 | +71.7% |
| 37 | OLMA | OLEMA PHARMACEUTICALS INC | $373K | 0.29% | -28,500 | -53.3% |
| 38 | GLUE | MONTE ROSA THERAPEUTICS INC | $370K | 0.29% | +22,500 | NEW |
| 39 | ONDS | ONDAS INC | $339K | 0.27% | +37,500 | NEW |
| 40 | ACOG | ALPHA COGNITION INC | $283K | 0.22% | — | HELD |
| 41 | MBX | MBX BIOSCIENCES INC | $269K | 0.21% | +9,000 | NEW |
| 42 | APC | ARKO PETE CORP | $268K | 0.21% | +15,000 | NEW |
| 43 | KYTX | KYVERNA THERAPEUTICS INC | $259K | 0.20% | +4,900 | +19.5% |
| 44 | RYZ | RYERSON HOLDING CORP | $243K | 0.19% | +10,800 | NEW |
| 45 | NKLR | TERRA INNOVATUM GLOBAL NV | $209K | 0.16% | — | HELD |
| 46 | INCY | INCYTE CORP | $188K | 0.15% | +2,000 | NEW |
| 47 | CAPR | CAPRICOR THERAPEUTICS INC | $152K | 0.12% | +3,500 | +233.3% |
| 48 | VPG | VISHAY PRECISION GROUP INC | $130K | 0.10% | +3,000 | NEW |
| 49 | ESPR | ESPERION THERAPEUTICS INC | $130K | 0.10% | — | HELD |
| 50 | AMLX | AMYLYX PHARMACEUTICALS INC | $125K | 0.10% | — | HELD |
| 51 | LSPD | LIGHTSPEED COMMERCE INC | $112K | 0.09% | — | HELD |
| 52 | CMPS | COMPASS PATHWAYS PLC | $86K | 0.07% | +15,500 | NEW |
| 53 | LTRX | LANTRONIX INC | $79K | 0.06% | +15,000 | NEW |
| 54 | SSYS | STRATASYS LTD | $78K | 0.06% | — | HELD |
| 55 | HIMS | HIMS &HERS HEALTH INC | $52K | 0.04% | +2,500 | NEW |
| 56 | PDSB | PDS BIOTECHNOLOGY CORP | $18K | 0.01% | — | HELD |
| 57 | — | CELCUITY INC COM MAR 20 26 $50 CALL (CELC) | — | — | -30,500 | EXITED |
| 58 | GPCR | STRUCTURE THERAPEUTICS INC | — | — | -38,500 | EXITED |
| 59 | FIGR | FIGURE TECHNOLOGY SOLUTIONS, INC | — | — | -57,500 | EXITED |
| 60 | SPOT | SPOTIFY TECHNOLOGY S.A. | — | — | -4,000 | EXITED |
| 61 | IBM | INTERNATIONAL BUS MACH CORP | — | — | -4,500 | EXITED |
| 62 | — | CELCUITY INC COM MAR 20 26 $35 CALL (CELC) | — | — | -12,500 | EXITED |
| 63 | EOG | EOG RESOURCES INC | — | — | -10,000 | EXITED |
| 64 | SNDK | SANDISK CORP | — | — | -3,500 | EXITED |
| 65 | DVN | DEVON ENERGY CORP | — | — | -22,000 | EXITED |
| 66 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES | — | — | -23,000 | EXITED |
| 67 | APGE | APOGEE THERAPEUTICS INC | — | — | -7,000 | EXITED |
| 68 | LQDA | LIQUIDIA CORPORATION | — | — | -8,500 | EXITED |
| 69 | BW | BABCOCK & WILCOX ENTERPRISES | — | — | -36,500 | EXITED |
| 70 | ALDX | ALDEYRA THERAPEUTICS | — | — | -41,000 | EXITED |
| 71 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS INC | — | — | -12,900 | EXITED |
| 72 | TVTX | TRAVERE THERAPEUTICS INC | — | — | -3,000 | EXITED |
| 73 | WY | WEYERHAEUSER CO MTN BE | — | — | -4,500 | EXITED |
| 74 | BHVN | BIOHAVEN LTD COM NPV | — | — | -7,500 | EXITED |
| 75 | BTC | GRAYSCALE BITCOIN MINI TR ETF | — | — | -1,800 | EXITED |
| 76 | NVNO | ENVVENO MED CORP COM | — | — | -115,000 | EXITED |
| 77 | YALA | YALLA GROUP LTD | — | — | -5,000 | EXITED |
| 78 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | — | — | -1,500 | EXITED |
Source: SEC EDGAR · accession 0001636587-26-000028. 13F discloses long positions only — shorts, foreign equities, and options are excluded.